News|Articles|October 28, 2024
ICP-MS and ICP-OES: Tools for Elemental Impurity Analysis
Author(s)Alcami
Elemental impurity testing is essential to deliver safe drug products to patients and is a regulatory requirement. It is important to assess the risk of elemental impurities from all sources in the manufacturing process, including process equipment, water, container/packaging, raw materials, drug substances, and the final drug product.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why Biopharma Developers Should Care About FDA’s New Personalized Therapy Approval Process
2
Chiesi–Aliada Partnership Advances BBB-Crossing Technology for Lysosomal Storage Disorders
3
How Advanced PK/TK Protocols Strengthen Data Integrity
4
